Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research6

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research6

FiltersClear all

Status

Active, not recruiting4
Completed1
Terminated1

Study type

Interventional5
Observational1

Phase

Not applicable5
Not reported1

Investigator

Geoffrey W Bergman6
Jim W. Cheung10
Brian DeRubertis8
James E. Ip8
Shmuel Chen6

Show all 50

Department

Medicine6

Condition

Aortic Valve Stenosis2
Coronary Artery Disease2
Acute Coronary Syndrome1
Angina Pectoris1
Atrial Fibrillation1

Intervention type

Device6
Drug1

Sponsor type

Industry6

Start date

Has results posted3

Geoffrey W Bergman×Device×Clear all

Showing 1–6 of 6 studiesSort:

Active, not recruitingInterventional · Not applicableNCT04226547 ↗
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants

FiltersClear all

Status

Active, not recruiting4
Completed1
Terminated1

Study type

Interventional5
Observational1

Phase

Not applicable5
Not reported1

Investigator

Geoffrey W Bergman6
Jim W. Cheung10
Brian DeRubertis8
James E. Ip8
Shmuel Chen6

Show all 50

Department

Medicine6

Condition

Aortic Valve Stenosis2
Coronary Artery Disease2
Acute Coronary Syndrome1
Angina Pectoris1
Atrial Fibrillation1

Intervention type

Device6
Drug1

Sponsor type

Industry6

Start date

Has results posted3

Geoffrey W Bergman×Device×Clear all

Showing 1–6 of 6 studiesSort:

Active, not recruitingInterventional · Not applicableNCT04226547 ↗
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants

Show fewer

Christopher F Liu5
Conor Liston5
Daniel W Skupski5
Michael G Kaplitt5
Reem Z. Sharaiha5
Manish Ashwin Parikh4
Joan Stilling4
Benjamin Samstein4
Abhishek Jaywant3
Christopher Lau3
David M. Otterburn3
Evelyn M. Horn3
Jared Knopman3
Neel Mehta3
Parag Goyal3
Peter Connolly3
Seth H. Goldbarg3
Shari Lipner3
Stephanie L. Mick3
Steven M Markowitz3
Anna Podolanczuk2
Bradley B Pua2
Gioia Turitto2
Harini Sarva2
Irina Sobol2
Jaikirshan Khatri2
Leonard N Girardi2
Mehraneh Dorna Jafari2
Rajesh Kumar Malik2
Reema Bhatt2
Shing Chiu Wong2
Timothy McClure2
Asad Riaz Siddiqi1
Adam D. Talenfeld1
Anais Rameau1
Anthony O. Ahmed1
Christopher Agrusa1
Cheguevara Afaneh1
Cora Sternberg1
David Leslie Carr-Locke1
Daniel Joseph Holzwanger1
David J Slotwiner1
Darshana M Dadhania1
Dmitriy N. Feldman1
Yuhei Kobayashi1

Show all 8

Show fewer

Hemorrhage1
Myocardial Ischemia1
Stroke1

Geoffrey W BergmanPI

Intervention: Device: Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder) · Drug: Non-Vitamin K Oral Antagonists
Dates: Jul 2020 – Jan 2029 (est.)
Sponsor: Abbott Cardiovascular Systems, Inc.

Atrial FibrillationStrokeBleeding

Active, not recruitingInterventional · Not applicableNCT04489823 ↗

PARADIGM PARAvalvular Leak Closure With the Amplatzer Valvular Plug occluDer for Interventional Transcatheter Closure for PVL With Surgical bioloGical and Mechanical Heart Valve

Geoffrey W BergmanPI

Intervention: Device: AVP III
Dates: Dec 2020 – Nov 2025
Sponsor: Abbott Cardiovascular Systems, Inc.

Paravalvular Aortic Regurgitation

Active, not recruitingInterventional · Not applicableNCT04722250 ↗

SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial

Geoffrey W BergmanPI

Intervention: Device: Medtronic Evolut PRO, Evolut PRO+ or Evolut FX (where commercially available) TAV Systems · Device: Edwards SAPIEN 3 or SAPIEN 3 Ultra THV Systems
Dates: Apr 2021 – Nov 2023· Results posted
Sponsor: Medtronic, Inc.

Symptomatic Aortic StenosisAortic Valve StenosisAortic Valve Replacement

Active, not recruitingInterventional · Not applicableNCT05893498 ↗

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

Yuhei KobayashiPIGeoffrey W BergmanPI

Intervention: Device: FFRangio · Device: FFR or NHPR
Dates: Jun 2023 – May 2026 (est.)
Sponsor: CathWorks, Inc.

Percutaneous Coronary Intervention

TerminatedInterventional · Not applicableNCT03618095 ↗

REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects

Geoffrey W BergmanPI

Intervention: Device: LOTUS Edge Valve System
Dates: Jan 2019 – Mar 2021· Results posted
Sponsor: Boston Scientific Corporation

Aortic Valve Stenosis

CompletedObservationalNCT04175626 ↗

BIOTRONIK - A Prospective Multicenter Study to Confirm the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - VII

Geoffrey W BergmanPI

Intervention: Device: Orsiro DES
Dates: Jan 2020 – Jan 2022· Results posted
Sponsor: BIOTRONIK GmbH & Co.

Coronary Artery DiseaseAtherosclerosis, CoronaryMyocardial Ischemia+3 more

Browse

Browse

Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants

Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants

PARADIGM PARAvalvular Leak Closure With the Amplatzer Valvular Plug occluDer for Interventional Transcatheter Closure for PVL With Surgical bioloGical and Mechanical Heart Valve

SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial

Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment

REPRISE IV: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of LOTUS Edge Valve System in IntermediatE Surgical Risk Subjects

BIOTRONIK - A Prospective Multicenter Study to Confirm the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - VII